WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)PULMONARY HYPERTENSION CARE CENTERS INC, founded in 2015, is a small nonprofit that reported $654K in total revenue in fiscal year 2022. Revenue surged 43% from the prior year, signaling strong growth momentum.
TO ESTABLISH A PROGRAM OF ACCREDITED CENTERS WITH EXPERTISE IN PULMONARY HYPERTENSION TO IMPROVE OVERALL QUALITY OF CARE AND LONG-TERM OUTCOMES OF PATIENTS WITH THIS LIFE THREATENING DISEASE.
PULMONARY HYPERTENSION CARE CENTERS (PHCC ACCREDITATION): THE PULMONARY HYPERTENSION ASSOCIATION (PHA) ESTABLISHED ITS PH CARE CENTERS (PHCC) PROGRAM TO ACCREDIT CENTERS NATIONWIDE WITH SPECIAL...
PULMONARY HYPERTENSION CARE CENTERS (PHCC ACCREDITATION): THE PULMONARY HYPERTENSION ASSOCIATION (PHA) ESTABLISHED ITS PH CARE CENTERS (PHCC) PROGRAM TO ACCREDIT CENTERS NATIONWIDE WITH SPECIAL EXPERTISE IN TREATING PULMONARY HYPERTENSION (PH), PARTICULARLY PULMONARY ARTERIAL HYPERTENSION (PAH), TO RAISE THE OVERALL QUALITY OF CARE AND OUTCOMES IN PATIENTS WITH THIS INCURABLE, PROGRESSIVE, LIFE-THREATENING RARE DISEASE. ESTABLISHED IN 2011, THE PHCC PROGRAM HAS ACCREDITED TWO TYPES OF CENTERS. CENTERS OF COMPREHENSIVE CARE (CCC) AND REGIONAL CLINICAL PROGRAMS (RCP). BOTH PHCC-ACCREDITED CCC'S AND RCP'S HAVE DEMONSTRATED A COMMITMENT TO ROVIDING EXPERT-LEVEL CARE BASED ON THE PULMONARY HYPERTENSION DIAGNOSIS AND TREATMENT CONSENSUS GUIDELINES. AT THE END OF 2022, THERE WERE 82 ACCREDITED CENTERS NATIONWIDE.
PULMONARY HYPERTENSION ASSOCIATION REGISTRY (PHAR): ACCREDITED PHCC'S HAVE AN OPPORTUNITY TO PARTICIPATE IN PHAR AS BOTH A QUALITY IMPROVEMENT PROCESS AND A RESEARCH ACTIVITY. A PATIENT REGISTRY IS...
PULMONARY HYPERTENSION ASSOCIATION REGISTRY (PHAR): ACCREDITED PHCC'S HAVE AN OPPORTUNITY TO PARTICIPATE IN PHAR AS BOTH A QUALITY IMPROVEMENT PROCESS AND A RESEARCH ACTIVITY. A PATIENT REGISTRY IS AN ORGANIZED SYSTEM THAT COLLECTS DATA TO EVALUATE CERTAIN OUTCOMES FOR A POPULATION OF PEOPLE WITH A MEDICAL CONDITION AND IS A USEFUL TOOL FOR QUALITY IMPROVEMENT OF CARE AND FOR RESEARCH OF RARE DISEASES SUCH AS PH. PHAR COLLECTS DATA FROM WHO GROUP 1 PH (PULMONARY ARTERIAL HYPERTENSIONPAH) AND WHO GROUP 4 PH (CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSIONCTEPH) WHO ARE STARTING EVALUATION AND/OR TREATMENT AT AN ACCREDITED PHCC. DATA IS COLLECTED IN CONJUNCTION WITH ROUTINE PH CARE TEAM VISITS APPROXIMATELY EVERY 3-6 MONTHS. AT THE END OF 2022, THERE WERE 68 CENTERS PARTICIPATING AND 12,323 PATIENTS EVER ENROLLED IN PHAR.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2022 | 2021 | Change | |
|---|---|---|---|
| Revenue | $653,851 | $456,589 | +0.4% |
| Expenses | $683,626 | $722,806 | -0.1% |
| Net Income | $-29,775 | $-266,217 | -0.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| DELPHINE YUNG | CHAIR | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| MATT WALL | TREASURER | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| ELIZABETH MIKLOS | SECRETARY | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOEL WIRTH | IMMEDIATE PAST CHAIR | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| COLLEEN BRUNETTI | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| JESSIE KOHLER | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| NICOLE CREECH | DIRECTOR | 3.00 |
Director
|
$0 | $0 | $0 |
| MATT GRANATO | PRESIDENT AND CEO | 3.00 |
Officer
Director
|
$0 | $8,333 | $286,096 |
| TONY LAHNSTON | PHA CHAIR | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| TESS ESPOSITO | VP - FINANCE | 3.00 |
Key Emp
|
$0 | $11,077 | $164,748 |
| KEVIN HEYEN | VP - DEVELOPMENT | 3.00 |
Highest
|
$0 | $0 | $102,068 |
| ELIZABETH JOSELOFF | VP - QUALITY CARE & RESEAR | 3.00 |
Highest
|
$0 | $16,263 | $157,926 |
| KAREN SMAALDERS | VP - COMMUNICATIONS | 1.00 |
Highest
|
$0 | $10,673 | $150,884 |
| KATHERINE KRONER | VP - ADVOCACY & PATIENT EN | 1.00 |
Highest
|
$0 | $10,249 | $136,326 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2022 | $653,851 | $683,626 | No data | $-29,775 |
| 2021 | $456,589 | $722,806 | $426,651 | $-266,217 |
| 2020 | $504,353 | $584,551 | $172,555 | $-80,198 |
| 2019 | $454,671 | $637,538 | $239,528 | $-182,867 |
| 2018 | $583,483 | $555,641 | $420,435 | $27,842 |
Compare PULMONARY HYPERTENSION CARE CENTERS INC with other nonprofits in District of Columbia and across the country.